ConductScience.org, home

Paper42943535PubMed

Clinical Characteristics of Coccidioidomycosis in Patients with Hepatitis C-Associated Cirrhosis.

Shepard R and 4 others. Microorganisms, 2026.

Cite this record

ConductScience Library. Clinical Characteristics of Coccidioidomycosis in Patients with Hepatitis C-Associated Cirrhosis. Papers, record 42943535. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42943535

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Clinical Characteristics of Coccidioidomycosis in Patients with Hepatitis C-Associated Cirrhosis.
Journal
Microorganisms
Year
2026
Publication types
Journal Article
Revised in PubMed
2026-10-28

Source PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shepard RRayne
2Nukala NNandinihttps://orcid.org/0009-0004-0991-8579
3Roytman MMarina
4Policepatil SSeema
5Sivasubramanian GGeethahttps://orcid.org/0000-0002-8443-7095

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References36

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115938383[Treatment of hepatitis C virus infection].Praxis (Bern 1994)2005https://conductscience.org/library/papers/15938383PubMed
240246701Impact of glycemic control on coccidioidomycosis outcomes in patients with underlying diabetes mellitus in central California.Med Mycol2025https://conductscience.org/library/papers/40246701PubMed
341580284Coccidioidomycosis in cirrhosis: A high-risk syndrome with severe outcomes.Am J Med Sci2026https://conductscience.org/library/papers/41580284PubMed
434133861The Evolving Challenge of Infections in Cirrhosis.N Engl J Med2021https://conductscience.org/library/papers/34133861PubMed
536983473Case Series of End-Stage Liver Disease Patients with Severe Coccidioidomycosis.J Fungi (Basel)2023https://conductscience.org/library/papers/36983473PubMed
612884198Incidence and prevalence of coccidioidomycosis in patients with end-stage liver disease.Liver Transpl2003https://conductscience.org/library/papers/12884198PubMed
739189034Clinical Characteristics and Mortality Risks Among Patients With Culture-Proven Coccidioidomycosis Who Are Critically Ill: A Multicenter Study in an Endemic Region.Open Forum Infect Dis2024https://conductscience.org/library/papers/39189034PubMed
835233706Coccidioidomycosis: A Contemporary Review.Infect Dis Ther2022https://conductscience.org/library/papers/35233706PubMed
921745274Hepatitis C virus infection in USA: an estimate of true prevalence.Liver Int2011https://conductscience.org/library/papers/21745274PubMed
1030959825Restoration of HCV-Specific Immune Responses with Antiviral Therapy: A Case for DAA Treatment in Acute HCV Infection.Cells2019https://conductscience.org/library/papers/30959825PubMed
1110492320Hepatic hydrothorax: pathogenesis, diagnosis, and management.Am J Med1999https://conductscience.org/library/papers/10492320PubMed
1227339680Infections in Liver Disease.Crit Care Clin2016https://conductscience.org/library/papers/27339680PubMed
1315118543Coccidioidomycosis: a descriptive survey of a reemerging disease. Clinical characteristics and current controversies.Medicine (Baltimore)2004https://conductscience.org/library/papers/15118543PubMed
14274702382016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis.Clin Infect Dis2016https://conductscience.org/library/papers/27470238PubMed
1528074358Genotype 3 Infection: The Last Stand of Hepatitis C Virus.Drugs2017https://conductscience.org/library/papers/28074358PubMed
1635792761Liver cirrhosis and immune dysfunction.Int Immunol2022https://conductscience.org/library/papers/35792761PubMed
1711229838Risk factors for severe pulmonary and disseminated coccidioidomycosis: Kern County, California, 1995-1996.Clin Infect Dis2001https://conductscience.org/library/papers/11229838PubMed
1834242330Partial restoration of immune response in Hepatitis C patients after viral clearance by direct-acting antiviral therapy.PLoS One2021https://conductscience.org/library/papers/34242330PubMed
1914586893Hepatitis C pathogenesis: mechanisms of viral clearance and liver injury.Liver Transpl2003https://conductscience.org/library/papers/14586893PubMed
2034016286Coccidioidomycosis.Infect Dis Clin North Am2021https://conductscience.org/library/papers/34016286PubMed

See all 36 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42943535

GET https://conductscience.org/api/papers/v1/42943535/references?page=2